Hjem › Ewing-sarkom › District of Columbia
Ewing-sarkom kliniske forsøg i District of Columbia
6 studier for Ewing-sarkom søger deltagere på steder i District of Columbia.
Byer i District of Columbia
Officiel studietekst (engelsk)
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Children's National Medical Center, Washington D.C.
RekruttererFase 1/2
12 Months – 30 Years · Alle køn · Opdateret 25. aug. 2026 · NCT04851119Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE)
- Children's National Hospital, Washington D.C.
- Childrens National Hospital, Washington D.C.
RekruttererFase 1
Alder 1 til 23 · Alle køn · Opdateret 13. aug. 2026 · NCT07172958Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma
- Sibley Memorial Hospital, Washington D.C.
Rekrutterer
Op til 39 år · Alle køn · Opdateret 13. jul. 2026 · NCT06796543Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
- Children's National Medical Center, Washington D.C.
RekruttererFase 1/2
12 Months – 30 Years · Alle køn · Opdateret 19. maj 2026 · NCT04901702Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
- Children's National Hospital, Washington D.C.
RekruttererFase 1/2
Alder 2 til 30 · Alle køn · Opdateret 3. feb. 2026 · NCT05734066A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
- Children's National Medical Center, Washington D.C.
RekruttererFase 2
18 Months – 40 Years · Alle køn · Opdateret 12. aug. 2025 · NCT05135975Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.